EUCTR2004-001298-24-ES进行中（未招募）1 期
An open-label, randomized, multicenter, parallel group study to demonstrate correction of anemia using intravenous injections of RO0503821 in patients with chronic kidney disease who are on dialysis
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 168
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Baseline predialysis (for HD patients) Hb concentration 8-11 g/dL determined from the mean of 2 screening values with at least one day between measurements
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Previous therapy with recombinant human erythropoetin or any other erythropoeitc substance within 12 weeks prior to screening. If epoetin treatment has been interrupted for at least 12 weeks, the patient may be enrolled in the study. Ongoing epoetin treatment should not be discontinued to allow participation in the trial.
研究者
相似试验
进行中（未招募）
1 期
An open-label, randomized, multicenter, parallel group study to demonstrate correction of anemia using once monthly subcutaneous injections of RO0503821 in patients with chronic kidney disease who are not on dialysis - N/AChronic renal anemiaMedDRA version: 8.1Level: LLTClassification code 10058124Term: Nephrogenic anemiaEUCTR2006-001434-41-FRF. Hoffmann-La Roche Ltd264
进行中（未招募）
不适用
An open-label, randomized, multicenter, parallel group study to demonstrate correction of anemia using once every four week subcutaneous injections of RO0503821 in patients with chronic kidney disease who are not on dialysis - CORDATUSEUCTR2006-001434-41-DEF. Hoffmann-La Roche Ltd300
进行中（未招募）
不适用
An open-label, randomized, multicenter, parallel group study to demonstrate correction of anemia using once every four weeks subcutaneous injections of RO0503821 in patients with chronic kidney disease who are not on dialysis - N/AChronic renal anemiaMedDRA version: 8.1Level: LLTClassification code 10058124Term: Nephrogenic anemiaEUCTR2006-001434-41-GRF. Hoffmann-La Roche Ltd300
进行中（未招募）
不适用
An open-label, randomized, multicenter, parallel group study to demonstrate correction of anemia using once monthly subcutaneous injections of RO0503821 in patients with chronic kidney disease who are not on dialysis - N/AChronic renal anemiaMedDRA version: 8.1Level: LLTClassification code 10058124Term: Nephrogenic anemiaEUCTR2006-001434-41-SEF. Hoffmann-La Roche Ltd264
进行中（未招募）
不适用
An open-label, randomized, multicenter, parallel group study to demonstrate correction of anemia using once monthly subcutaneous injections of RO0503821 in patients with chronic kidney disease who are not on dialysis. - CORDATUSChronic renal anemiaMedDRA version: 14.1Level: PTClassification code 10058116Term: Nephrogenic anaemiaSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2006-001434-41-ITROCHE264